Urologic Oncology

The Urologic Oncology program focuses on the investigation and management of urologic cancers: cancers of the prostate, bladder, kidney, testis and genitalia. It is the goal of the Urologic Oncology Program to provide timely, innovative, expert and compassionate care to those with urological malignancies or those at risk of developing them. Treatment plans are tailored to individual patient needs.

A multidisciplinary approach both in laboratory and clinical settings is emphasized. Members of this program are well-recognized clinicians and basic scientists who have contributed significantly to their fields. Their record of development of innovative patient treatment schemes, accrual to clinical studies, publication and funding is superior.

A broad-based translational research program is underway which includes researchers from a variety of disciplines. We feel that important insights into prevention, diagnosis and treatment will be based on close collaboration between our research program and faculty from many departments and divisions here at UCSF, including Biochemistry and Biophysics, Molecular and Cellular Pharmacology, Anatomy, Pharmaceutical Chemistry, Pathology, Medicine, Laboratory Medicine, Urology, Radiation Oncology and Radiology.

Currently, grants or awards totaling in excess of one million dollars have been awarded to members of this program. The program was recognized in 2000 when it was awarded a Specialized Program of Research Excellence (SPORE) grant by the National Cancer Institute (NCI). UCSF features one of the best, most comprehensive prostate cancer research programs in the United States. In addition, many program members have established research collaborations on other NCI-funded grants.

return to top